$ACHV|4May 22, 9:34 AM ET

ONCOGENEX PHARMACEUTICALS, INC. 4

4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed May 22, 2015

Form 4

Period: 2015-05-20

Director

Transactions

Exercise/Conversion
Common Stock
2015-05-20+2,500→ 14,562 total
Exercise/Conversion
Restricted Stock Unit (RSU)
2015-05-20−2,500→ 0 total
From: 2015-05-20→ Common Stock (2,500 underlying)
Award
Stock Option (right to buy)
2015-05-21+5,000→ 5,000 total
Exercise: $1.89Exp: 2025-05-21→ Common Stock (5,000 underlying)
Award
Restricted Stock Unit (RSU)
2015-05-21+2,500→ 2,500 total
→ Common Stock (2,500 underlying)

Footnotes (6)

[F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
[F2]RSUs convert into common stock on a one-for-one basis.
[F3]Each RSU represents a contingent right to receive one share of the issuer's common stock.
[F4]The RSUs expire 30 days from the date they vest.
[F5]The options vest 100% on the earlier of May 21, 2016 or the date immediately prior to the issuer's next annual meeting of stockholders.
[F6]The RSUs vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders, if this date is when the issuer's trading window is closed, it will vest the first day thereafter during which the issuer's trading window is open.

Documents

1 file